Cargando…
Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis
BACKGROUND: Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery. Aprokam is the only licensed product for prophylaxis of POE, although unlicensed intracameral cefuroxime may be administered using pre-filled syringes (PFS), eith...
Autores principales: | Purslow, Christine, Davey, Keith, Johnson, Mildred, Pietri, Guilhem, Suri, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495806/ https://www.ncbi.nlm.nih.gov/pubmed/26152124 http://dx.doi.org/10.1186/s12886-015-0056-5 |
Ejemplares similares
-
Effect of Intracameral Ophthalmic Cefuroxime Solution (Aprokam(®)) in the Prophylaxis of Cataract Surgery in Patients with Keratoplasty
por: Cicik, Mustafa Erdoğan, et al.
Publicado: (2018) -
Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis
por: Al-Abduljabbar, Khaled A., et al.
Publicado: (2017) -
Using intracameral cefuroxime as a prophylaxis for endophthalmitis
por: Yorston, David
Publicado: (2008) -
Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India
por: Rathi, Varsha M, et al.
Publicado: (2020) -
Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness
por: Linertová, Renata, et al.
Publicado: (2014)